What Is Upneeq?: The Story Behind The New Innovative Eyedrop
Manage episode 372403756 series 3423840
On this week’s episode of Skytale Insights, we welcome JD Schaub, EVP and Chief Operating Officer at RVL Pharmaceuticals, to the podcast! JD and Judy Kozlicki sat down to discuss Upneeq, an innovative FDA approved prescription eyedrop for acquired ptosis!
Judy and JD talk about advances in ocular aesthetics and the making of Upneeq. Plus, JD gives us a behind the scenes look at RVL Pharma and the studies performed to create this new innovative prescription eyedrop.
Connect with JD Schaub:
Connect with Skytale Group:
50 episodes